By Pushkala Aripaka (Reuters) -Sensodyne toothpaste maker Haleon on Thursday forecast high single-digit percentage growth in ...

Pfizer sold its remaining 7.3% stake in Haleon for $3.1 billion, fully exiting its position in the company. Haleon expects 2025 organic revenue growth of 4% to 6%, with stronger performance in the ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.

Haleon reported organic revenue growth of 3.5 per cent in the first quarter of 2025, driven by strong innovation and in-market execution across all categories and regions.

Pfizer’s effective tax rate on Reported (2) income for the first quarter of 2025 is negative, primarily due to favorable global income tax resolutions in multiple tax jurisdictions spanning ...

(Reuters) -Sensodyne toothpaste maker Haleon said on Thursday it expects high single-digit percentage growth in its operating ...